Urologic Oncology: Biomarkers, Diagnosis, and Management
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".
Deadline for manuscript submissions: 30 September 2024 | Viewed by 74
Special Issue Editors
2. Department of Urology, IRCCS Humanitas Research Hospital, Rozzano, Italy
Interests: endourology; bladder cancer; urologic oncology
Special Issue Information
Dear Colleagues,
This Special Issue aims to comprehensively explore cutting-edge research in the field, with a particular focus on biomarkers, diagnostic advancements, and innovative management strategies. We invite contributions that delve into the latest developments that shape our understanding of urologic oncology, fostering a collaborative exchange of insights to advance patient care. As we navigate the intricate landscape of urologic malignancies, this Special Issue endeavors to spotlight emerging trends and breakthroughs, catalyzing impactful discussions within our scientific community.
Dr. Roberto Contieri
Dr. Giovanni Lughezzani
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- urologic oncology
- biomarkers
- diagnosis
- management
- urothelial carcinoma
- prostate cancer
- kidney cancer
- testis cancer
- penile cancer
